Your browser doesn't support javascript.
loading
Flexible and Lightweight Devices for Wireless Multi-Color Optogenetic Experiments Controllable via Commercial Cell Phones.
Mayer, Philipp; Sivakumar, Nandhini; Pritz, Michael; Varga, Matjia; Mehmann, Andreas; Lee, Seunghyun; Salvatore, Alfredo; Magno, Michele; Pharr, Matt; Johannssen, Helge C; Troester, Gerhard; Zeilhofer, Hanns Ulrich; Salvatore, Giovanni Antonio.
Afiliación
  • Mayer P; Electronics Laboratory, ETH Zurich, Zurich, Switzerland.
  • Sivakumar N; Institute for Integrated Circuits, ETH Zurich, Zurich, Switzerland.
  • Pritz M; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
  • Varga M; Electronics Laboratory, ETH Zurich, Zurich, Switzerland.
  • Mehmann A; Electronics Laboratory, ETH Zurich, Zurich, Switzerland.
  • Lee S; Electronics Laboratory, ETH Zurich, Zurich, Switzerland.
  • Salvatore A; Department of Mechanical Engineering, Texas A&M University, College Station, TX, United States.
  • Magno M; Sensor ID, Campochiaro, Italy.
  • Pharr M; Institute for Integrated Circuits, ETH Zurich, Zurich, Switzerland.
  • Johannssen HC; Department of Mechanical Engineering, Texas A&M University, College Station, TX, United States.
  • Troester G; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
  • Zeilhofer HU; Electronics Laboratory, ETH Zurich, Zurich, Switzerland.
  • Salvatore GA; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Front Neurosci ; 13: 819, 2019.
Article en En | MEDLINE | ID: mdl-31551666
Optogenetics provide a potential alternative approach to the treatment of chronic pain, in which complex pathology often hampers efficacy of standard pharmacological approaches. Technological advancements in the development of thin, wireless, and mechanically flexible optoelectronic implants offer new routes to control the activity of subsets of neurons and nerve fibers in vivo. This study reports a novel and advanced design of battery-free, flexible, and lightweight devices equipped with one or two miniaturized LEDs, which can be individually controlled in real time. Two proof-of-concept experiments in mice demonstrate the feasibility of these devices. First, we show that blue-light devices implanted on top of the lumbar spinal cord can excite channelrhodopsin expressing nociceptors to induce place aversion. Second, we show that nocifensive withdrawal responses can be suppressed by green-light optogenetic (Archaerhodopsin-mediated) inhibition of action potential propagation along the sciatic nerve. One salient feature of these devices is that they can be operated via modern tablets and smartphones without bulky and complex lab instrumentation. In addition to the optical stimulation, the design enables the simultaneously wireless recording of the temperature in proximity of the stimulation area. As such, these devices are primed for translation to human patients with implications in the treatment of neurological and psychiatric conditions far beyond chronic pain syndromes.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Neurosci Año: 2019 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Neurosci Año: 2019 Tipo del documento: Article País de afiliación: Suiza